Plus, news about Maat Pharma, Secretome Therapeutics, 35Pharma, Medigene and Doron Therapeutics:
Aviceda Therapeutics’ $200M financing: The Boston-area biotech is looking to raise a $200 million equity round, according to an SEC
↧